dipyridamole has been researched along with Calcinosis in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Calcinosis: Pathologic deposition of calcium salts in tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with dipyridamole decreased high glucose-induced osteopontin expression and secretion." | 1.36 | Dipyridamole suppresses high glucose-induced osteopontin secretion and mRNA expression in rat aortic smooth muscle cells. ( Chi, WM; Hsieh, MS; Lee, HM; Lin, JY; Yu, SC; Zhong, WB, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, MS | 1 |
| Zhong, WB | 1 |
| Yu, SC | 1 |
| Lin, JY | 1 |
| Chi, WM | 1 |
| Lee, HM | 1 |
| Gould, KL | 1 |
| Vasudev, SC | 2 |
| Chandy, T | 2 |
| Sharma, CP | 1 |
| Rao, GH | 1 |
| Wagoner, LE | 1 |
| Movahed, A | 1 |
| Reeves, WC | 1 |
| Mackay, A | 1 |
| de Bono, DP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of Coronary Revascularization on Absolute Myocardial Blood Flow as Assessed by Stress Myocardial Positron Tomography[NCT02931331] | 50 participants (Anticipated) | Observational [Patient Registry] | 2016-03-31 | Enrolling by invitation | |||
| Pilot Study on the Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis[NCT00940862] | Phase 4 | 30 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dipyridamole and Calcinosis
| Article | Year |
|---|---|
Positron emission tomography in coronary artery disease.
Topics: Calcinosis; Coronary Artery Disease; Coronary Vessels; Dipyridamole; Disease Progression; Humans; Pa | 2007 |
Positron emission tomography in coronary artery disease.
Topics: Calcinosis; Coronary Artery Disease; Coronary Vessels; Dipyridamole; Disease Progression; Humans; Pa | 2007 |
Positron emission tomography in coronary artery disease.
Topics: Calcinosis; Coronary Artery Disease; Coronary Vessels; Dipyridamole; Disease Progression; Humans; Pa | 2007 |
Positron emission tomography in coronary artery disease.
Topics: Calcinosis; Coronary Artery Disease; Coronary Vessels; Dipyridamole; Disease Progression; Humans; Pa | 2007 |
5 other studies available for dipyridamole and Calcinosis
| Article | Year |
|---|---|
Dipyridamole suppresses high glucose-induced osteopontin secretion and mRNA expression in rat aortic smooth muscle cells.
Topics: Animals; Antioxidants; Aorta; Biomarkers; Calcinosis; Cells, Cultured; Diabetic Angiopathies; Dipyri | 2010 |
Glutaraldehyde treated bovine pericardium: changes in calcification due to vitamins and platelet inhibitors.
Topics: Animals; Ascorbic Acid; Aspirin; Biological Transport; Bioprosthesis; Calcinosis; Calcium; Calcium P | 1997 |
Changes in pericardial calcification due to antiplatelet agents: in vitro studies.
Topics: Anesthetics, Intravenous; Animals; Anti-Bacterial Agents; Aspirin; Bioprosthesis; Calcinosis; Cattle | 1998 |
Myocardial imaging artifacts caused by mitral valve annulus calcification.
Topics: Aged; Aged, 80 and over; Calcinosis; Coronary Disease; Dipyridamole; Female; Humans; Mitral Valve; R | 1991 |
Valvar aortic stenosis in adults: an update.
Topics: Adult; Anticoagulants; Aortic Valve Stenosis; Aspirin; Calcinosis; Dipyridamole; Echocardiography; E | 1986 |